US2002197316A1PendingUtilityA1
Dosage form comprising means for changing drug delivery shape
Priority: Sep 9, 1997Filed: Aug 8, 2002Published: Dec 26, 2002
Est. expirySep 9, 2017(expired)· nominal 20-yr term from priority
A61K 9/0004
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A dosage form is disclosed comprising means for delivering essentially a total dose of drug.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A dosage form for delivering a drug to a patient in need of the drug, wherein the dosage form comprises: an orally administrable therapeutic composition comprising a dose of drug and a pharmaceutically acceptable polymer carrier for transporting the drug from the dosage form; a membrane that surrounds the therapeutic composition, which membrane comprises a polymer permeable to the passage of fluid, a plasticizer, a surfactant, and a binder; and an exit in the membrane for delivering the drug at a sustained-release rate over an extended time.
2 . The dosage form for delivering the drug according to claim 1 , wherein the membrane changes shape during the operation of the dosage form.
3 . A dosage form for delivering the drug according to claim 1 , wherein the binder is compatible with and binds the polymer, plasticizer, and surfactant into the membrane.
4 . The dosage form for delivering a drug to a patient in need of the drug, wherein the dosage form comprises: an orally administrable therapeutic composition comprising a dose of drug and a pharmaceutically acceptable polymer carrier for transporting the drug from the dosage form; a displacement composition comprising a polymer that expands in the presence of an aqueous fluid and thereby pushes the therapeutic composition from the dosage form; a membrane that surrounds the therapeutic composition and the displacement composition, which membrane comprises a polymer permeable to the passage of an aqueous fluid, a plasticizer, a surfactant, and a binder; and an exit in the membrane for delivering the drug at a sustained-release rate over an extended time.
5 . The dosage form for delivering the drug according to claim 3 , wherein the membrane possesses a surface that faces the therapeutic composition and the displacement composition and a surface that faces the patient and carries thereon a dose of drug.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.